The authors concluded that it is critical to understand the factors regulating CD47 gene expression at the transcriptional level, since this could lead to alternative targeted cancer gene therapies, allowing for the recruitment of the host’s innate immune system, to specifically recognize and destroy cancer tumorigenic cells. The gene discussed is CD47; the disease is cancer.